-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VAC-85135 in Essential Thrombocythemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAC-85135 in Essential Thrombocythemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VAC-85135 in Essential ThrombocythemiaDrug Details:VAC-85135 is under development for the treatment of essential...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VAC-20121 in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAC-20121 in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VAC-85135 in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAC-85135 in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VAC-85135 in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details:VAC-85135 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divarasib in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Divarasib in Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Divarasib in Breast Cancer Drug Details: Divarasib (GDC-6036 (RG6330)) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Lirafugratinib Hydrochloride in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lirafugratinib Hydrochloride in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lirafugratinib Hydrochloride in Bile Duct Cancer (Cholangiocarcinoma) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PH-10 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PH-10 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PH-10 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: PH-10 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: iNeo-Vac-R01 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Pancreatic Cancer Drug Details: iNeo-Vac-R01 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Gastrointestinal Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Gastrointestinal Tract Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Gastrointestinal Tract Cancer Drug Details: iNeo-Vac-R01 is under development...